Phase 2/3 clinical trial for critically ill COVID-19 patients continues to enroll patients as cases surge across the country

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holdings AG today announced that the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track FDA trials of RLF-100 (Aviptadil) in patients with Critical COVID-19 with respiratory failure. The study protocol enrolls patients with Critical COVID-19 and Respiratory Failure and [...]

The post Phase 2/3 clinical trial for critically ill COVID-19 patients continues to enroll patients as cases surge across the country appeared first on Outbreak News Today.